MedPath

Rudioretic supplement and kidney stone

Phase 3
Conditions
N20.0
Kidney stone.
Calculus of kidney
Registration Number
IRCT20140804018677N12
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
160
Inclusion Criteria

Diagnosed with a kidney stone without hydronephrosis and no need for medication
Age between 18-45 years
Willing to participate in the study

Exclusion Criteria

Pregnancy or lactation
Having known heart disease
Receiving drugs that affect kidney stones

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of excreted kidney stone. Timepoint: Start of intervention and a month later. Method of measurement: Ultrasonography and blood and urine tests.;Stone size. Timepoint: Start of intervention and a month later. Method of measurement: Sonography.
Secondary Outcome Measures
NameTimeMethod
rine volume 24 h. Timepoint: Start of intervention and a month later. Method of measurement: Urine 24 h test by BT-1500 autoanalyser.;Creatinine in urine 24h. Timepoint: Start of intervention and a month later. Method of measurement: Urine 24h test by Pars Azmoon kit.;Oxalate in urine 24 h. Timepoint: Start of intervention and a month later. Method of measurement: urine 24 h test by Darmankau kit.;Citrate in urine 24 h. Timepoint: Start of intervention and a month later. Method of measurement: urine 24 h test by Darmankau kit.;Uric acid in urine 24 h. Timepoint: Start of intervention and a month later. Method of measurement: urine 24h test by Pars Azmoon kit.;Urine specific gravity. Timepoint: Start of intervention and a month later. Method of measurement: Urinalysis by BT-1500 autoanalyser.
© Copyright 2025. All Rights Reserved by MedPath